TY - JOUR AU - Zhu, Quing AU - Tannenbaum, Susan AU - Kurtzman, Scott H. AU - DeFusco, Patricia AU - Ricci, Andrew AU - Vavadi, Hamed AU - Zhou, Feifei AU - Xu, Chen AU - Merkulov, Alex AU - Hegde, Poornima AU - Kane, Mark AU - Wang, Liqun AU - Sabbath, Kert PY - 2018 DA - 2018/06/14 TI - Identifying an early treatment window for predicting breast cancer response to neoadjuvant chemotherapy using immunohistopathology and hemoglobin parameters JO - Breast Cancer Research SP - 56 VL - 20 IS - 1 AB - Breast cancer pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) varies with tumor subtype. The purpose of this study was to identify an early treatment window for predicting pCR based on tumor subtype, pretreatment total hemoglobin (tHb) level, and early changes in tHb following NAC. SN - 1465-542X UR - https://doi.org/10.1186/s13058-018-0975-1 DO - 10.1186/s13058-018-0975-1 ID - Zhu2018 ER -